We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOTK:NASDAQSono-Tek Corporation Analysis

Data as of 2026-08-31 - not real-time

$4.93

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Sono-Tek Corporation trades at $4.92, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 8.5%. Momentum indicators put RSI at 40.2 (neutral) with MACD reading bearish. The recent range runs from support at $4.86 up to resistance at $5.69.
On valuation the read is fair — earnings multiple of 37.9 versus a 35.7 sector average, in line with the peer group. Consensus targets land 52.3% above where the shares trade now. Revenue is growing at 10.3% on a 9.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 40.5%, a beta of 0.84 and a maximum drawdown of 23.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 4 out of 10.

Top Market Events

Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67%...Sono-Tek Corporation SOTK came out with quarterly earnings of $0.Hosted on MSN20dSono-Tek shares rise after record $3.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 4.57
  • MACD momentum is negative
  • 30-day price change of -8.5%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 37.9 versus sector average of 35.7
  • Trading above the 200-day average of 4.57
  • Analyst targets imply +52.3% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 37.9 versus sector average of 35.7
  • Analyst targets imply +52.3% versus the current price
  • Revenue growth of +10.3%

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin9.62%
P/E Ratio37.9
ROE10.60%
ROA5.68%
P/B Ratio3.8
Op. Cash Flow$6.1M
Free Cash Flow$4.4M
Industry P/E35.7

Technical Analysis

TrendNeutral
RSI40.2
Support$4.86
Resistance$5.69
MA 20$5.22
MA 50$5.31
MA 200$4.57
MACDBearish
VolumeDecreasing
Fear & Greed Index94.2

Valuation

Fair Value$6.58
Target Price$7.50
Upside/Downside52.28%
GradeFair
TypeGrowth

Risk Assessment

Beta0.84
Volatility40.51%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.